Provided by Tiger Trade Technology Pte. Ltd.

AQR Capital Holdings

2,685.43
+29.831.12%
Number of Gainers:57
Number of Losers:39
Number of Flat:2
PE:- -
High:2,697.11
Open:2,655.45
Low:2,655.45
Close:2,655.60
Volume:1.18B
Turnover:239.15B
Market Cap:49.12T
Float Cap:45.71T

Loading ...

SK Hynix vs. Micron: Which AI Memory Stock, SKHY or MU, Is Better for Long-Term Holding?

TradingKey
·
Sep 26

Wall Street Closes Higher as All Three Major Indexes Gain and Post Weekly Advances, Shrugging Off Bond Selloff; Apple Sets Another Record

Deep News
·
Sep 26

Public Storage Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 26

Keysight Technologies Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Sep 26

W.W. Grainger Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 26

Monolithic Power Systems Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Sep 26

Adobe Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 26

Global Markets-Battered Bonds Draw Support from Falling Oil Prices

Reuters
·
Sep 26

Coca-Cola Taps Monster Exec as President of North American Unit

Dow Jones
·
Sep 26

Merck, Daiichi Sankyo Withdraw US Application for Lung Cancer Drug

Reuters
·
Sep 26

Averages Closing 65 Stocks

Dow Jones
·
Sep 26

Merck, Daiichi Sankyo voluntarily withdraw BLA for ifinatamab deruxtecan

TIPRANKS
·
Sep 26

Intel Corp. Stock Sheds 3.4%, Underperforms Peers

Dow Jones
·
Sep 26

Citigroup Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 26

Microsoft Corp. Stock Advances 3.7%, Outperforms Peers

Dow Jones
·
Sep 26

Texas Instruments Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 26

PayPal Holdings Inc. Stock Rises 4.6%, Outperforms Peers

Dow Jones
·
Sep 26

OpenAI Works to Understand Full Scope of Agent Activity as User Data Leak Emerges

Reuters
·
Sep 26

Merck & Co - Daiichi Sankyo and Merck Withdraw Bla for Ifinatamab Deruxtecan in Es-Sclc in U.S.

THOMSON REUTERS
·
Sep 26

Merck & Co - Withdrawal Based on FDA Discussions; Phase 2 Data Do not Satisfy Approval Requirements

THOMSON REUTERS
·
Sep 26